- Home
- OSUR
as 03-31-2025 4:00pm EST
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | BETHLEHEM |
| Market Cap: | 260.3M | IPO Year: | 1986 |
| Target Price: | $5.50 | AVG Volume (30 days): | 697.8K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.69 - $6.35 | Next Earning Date: | 05-07-2025 |
| Revenue: | $185,827,000 | Revenue Growth: | -54.17% |
| Revenue Growth (this year): | -25.55% | Revenue Growth (next year): | 7.46% |
Stock Insider Trading Activity of OraSure Technologies Inc. (OSUR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| EGLINTON MANNER CARRIE | OSUR | President & CEO | Feb 28 '25 | Buy | $3.49 | 28,670 | $100,026.76 | 1,288,334 | |
| EGLINTON MANNER CARRIE | OSUR | President & CEO | Feb 27 '25 | Buy | $3.15 | 78,625 | $247,377.84 | 1,288,334 | |
| McGrath Kenneth J | OSUR | Chief Financial Officer | Feb 27 '25 | Buy | $3.15 | 64,000 | $201,683.20 | 371,013 | |
| Gagliano Nancy J | OSUR | Director | Feb 27 '25 | Buy | $3.08 | 12,750 | $39,270.00 | 91,524 | |
| Kenny John P. | OSUR | Director | Feb 27 '25 | Buy | $3.17 | 47,659 | $151,217.24 | 70,915 | |
| Marmora Lelio | OSUR | Director | Feb 27 '25 | Buy | $3.06 | 7,000 | $21,420.00 | 67,720 |
Latest OraSure Technologies Inc. News
OSUR Breaking Stock News: Dive into OSUR Ticker-Specific Updates for Smart Investing
Argus Research
13 hours ago
Daily – Vickers Top Insider Picks for 03/31/2025
Argus Research
4 days ago
Daily – Vickers Top Insider Picks for 03/28/2025
Argus Research
5 days ago
Daily – Vickers Top Insider Picks for 03/27/2025
Argus Research
6 days ago
Daily – Vickers Top Insider Picks for 03/26/2025
Argus Research
7 days ago
Daily – Vickers Top Insider Picks for 03/25/2025
MT Newswires
7 days ago
OraSure Technologies' Board Approves Up to $40 Million Stock Buyback Plan
GlobeNewswire
7 days ago
OraSure Announces $40 Million Stock Repurchase Program
Argus Research
8 days ago
Daily – Vickers Top Insider Picks for 03/24/2025
Compare OSUR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OSUR OraSure Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.